PTAB Holds Patent Eligible for Post-Grant Review After Petitioner Successfully Demonstrates that Patent Is Not Entitled to Earliest Claimed Priority Date

Sep 12, 2016

Reading Time : 2 min

Under the America Invents Act, PGR is available only for patents that have “at least one claim with an effective filing date on or after March 16, 2013, with ‘effective filing date’ having the definition given to it by 35 U.S.C. § 100(i).” If the effective filing date is prior to March 16, 2013, then the patent is ineligible for PGR. According to 35 U.S.C. § 100(i), the effective filing date is the filing date of the earliest application for which the patented invention is entitled. In instances when a patent is not entitled to any earlier filing date or right of priority, the effective filing date is the filing date of the patent itself. Id. 35 U.S.C. § 100(i).

The parties here disputed the effective filing date of the ’017 patent. The patent owner argued that the ’017 patent was entitled to the benefit of a series of earlier applications, the earliest of which was filed on October 25, 2002. Conversely, petitioner argued that the ’017 patent was not entitled to such benefit and that the effective filing date was March 24, 2014 (i.e., the filing date of the ’017 patent itself). The PTAB agreed with petitioner. Specifically, the PTAB found that all challenged claims require: (1) a heat transfer composition with a low toxicity refrigerant that essentially consists of 2,3,3,3-tetrafluorpropene (HFO-1234yf); (2) a lubricant that consists essentially of polyalkylene glycol(s) (PAG); and (3) a specific heat transfer application—automobile air conditioning. In reaching its determination, the PTAB noted that the earlier filed applications disclosed “blazemarks” to the general use of tetrafluorpropene and PAG lubricants and a “single passing reference” to automobile air conditioning.  However, that was insufficient.  Instead, the PTAB concluded that the earlier filed applications did “not enable the subject matter recited in [the challenged claims]” and failed to “provide sufficient guidance to demonstrate possession of the claimed subject matter as a whole, i.e., the combination of HFO-1234yf and [PAG] lubricant for automobile air conditioning.” Accordingly, the PTAB held that the ’017 patent had an effective filing date of March 26, 2014 and was thus eligible for PGR.

In the event that the ’017 patent was deemed ineligible for PGR, petitioner had also filed an inter partes review petition concurrent with its PGR petition. In view of the above determination, petitioner’s inter partes review petition was denied.

Arkema Inc., et al. v. Honeywell Intl. Inc., Case Nos. PGR2016-00011, Paper No. 13, PGR2016-00012, Paper No. 13, and IPR2016-00643, Paper No. 11 (PTAB, Sep. 2, 2016).

Share This Insight

Previous Entries

IP Newsflash

June 6, 2025

In a precedential opinion, the Federal Circuit definitively held that the Patent Trial and Appeal Board has jurisdiction over IPRs that concern expired patents....

Read More

IP Newsflash

June 6, 2025

In a patent infringement litigation in the U.S. District Court for the Eastern District of Texas, Judge Rodney Gilstrap denied a joint motion to stay the litigation
pending resolution of inter partes review when it was uncertain that all defendants would be bound by the statutory estoppel provision of 35 U.S.C. § 315(e).
...

Read More

IP Newsflash

May 30, 2025

A district court recently dismissed a patent infringement complaint for improper venue under 28 U.S.C. § 1400(b), finding that the storage and distribution of
products from an Amazon warehouse was not sufficient to establish that warehouse as a regular and established place of business in the district.
...

Read More

IP Newsflash

May 27, 2025

The Federal Circuit affirmed a District of Delaware finding of non-infringement in an ANDA litigation due to the patentee’s clear and unmistakable disavowal
of claim scope during prosecution. Specifically, the court held that statements made during prosecution of a parent application before the asserted claims
were allowed amounted to a prosecution disclaimer that extended to subsequent patents in the family. In reaching this conclusion, the court rejected an
attempt by the patentee to resurrect the claim scope through a unilateral, self-serving statement made in later applications in the family.
...

Read More

IP Newsflash

May 13, 2025

The Federal Circuit recently affirmed a district court’s holding that patent term extension (PTE) for a reissued patent was properly based on the issue date of
the original patent and not that of the reissued patent. The Federal Circuit concluded that, where both the original and reissued patents claimed a drug
product under regulatory review, using the issue date of the original patent to calculate PTE comports with both the purpose of the Hatch-Waxman Act and
the related statutory context.
...

Read More

IP Newsflash

May 12, 2025

The Patent Trial and Appeal Board recently declined to institute a petition for IPR that was filed on the same day that the petitioner filed another petition
challenging the same claims of the same patent. The board was not persuaded by petitioner’s arguments that a second petition was needed due to alleged
claim construction issues or the number, length or scope differences of the challenged claims.
...

Read More

IP Newsflash

May 9, 2025

The USPTO Director vacated the board’s decision to institute inter partes review based on an erroneous application of the Fintiv factors. Specifically, the
Director found that the board placed too much emphasis on Petitioner’s Sotera stipulation, and not enough emphasis on the investment in the parallel
litigation. Weighing the factors as a whole, the Director determined that institution should be denied.
...

Read More

IP Newsflash

May 9, 2025

In an institution decision following the USPTO’s withdrawal of its Fintiv Memo, the board addressed discretionary denial of an IPR under Fintiv in view of a
parallel ITC investigation. The board noted it would not consider the now-rescinded June 2022 memo from then-director Vidal which instructed that the PTAB
would not deny institution of an IPR or PGR under Fintiv when the request is based on a parallel ITC investigation. The board conducted a Fintiv analysis in
view of the ITC investigation, but ultimately determined that discretionary denial was not warranted in this particular situation.
...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.